News Overview

Pursuant to Regulation 30, 33 and 42 read with Schedule III and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please be informed that the Board of Directors of the Company at its meeting held today, inter alia, has: Approved the appointment of Mr. Kiran Hiralal Bhansali (DIN: 05243336) as the Additional Director (designated as Whole-Time Director) of the Company w.e.f. 23rd April, 2022 to hold office upto the ensuing Annual General Meeting.Approved the appointment of Mr. Kiran Hiralal Bhansali (DIN: 05243336) as the Whole-Time Director of the Company for a period of 5 years w.e.f. 23rd April, 2022 to 22nd April, 2027 subject to the approval of the Members in the ensuing Annual General Meeting.

TVS Motor Company Limited has informed the Exchange about press release dated 25-Apr-2022 titled TVS Motor Company and PETRONAS Partner to Form PETRONAS TVS Racing Team

MindTree Limited has informed the Exchange about press release dated 25-Apr-2022 titled Mindtree and Sapiens Announce Partnership to Digitally Transform the Insurance Industry

Outcome of Board meeting held today i.e. on April 25, 2022 under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Thomas Cook (India) Limited has informed the Exchange about press release dated 25-Apr-2022 titled ???Thomas Cook India successfully manages the prestigious ground breaking ceremony for the WHO Global Centre for Traditional Medicine for Ministry of Ayush GOI & the World Health Organisation (WHO)???

Bank Of India has informed the Exchange about Board Meeting held on 25-Apr-2022 to consider Fund raising

Meghmani Finechem Limited has informed the Exchange about Investor Presentation

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 25-Apr-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Clobetasol Propionate Foam, 0.05%

Arihant Capital Markets Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

HBSL : Significant movement in price has been observed in HB Stockholdings Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. HB Stockholdings Limited has submitted their response.